<samp id="z604p"><th id="z604p"></th></samp>
<delect id="z604p"><center id="z604p"></center></delect>

<optgroup id="z604p"><strike id="z604p"></strike></optgroup>
  • <video id="z604p"><th id="z604p"></th></video>

      <u id="z604p"></u>
    1. <video id="z604p"><input id="z604p"></input></video>
      1. Join Nasal-Phyto Company News Technical Support 中文

        Join Nasal-Phyto Company News Technical Support Chinese

        Categories Of News

        Parkinson's New Drug! Inbrija, the first inhaled levodopa product, launched in the US to treat OFF s

        Author:adminTime:2019/12/5 21:22:33Click:1730

        March 4, 2019 / BIOON /-Biocor Therapeutics has announced the launch of Inbrija (levodopa inhalation powder) in the US market. The drug was approved by the US FDA on December 21, 2018 for use in Intermittent treatment for patients with Parkinson's di····

        Read More

        New drugs that benefit 340 million patients worldwide are expected to be declared for listing next y

        Author:adminTime:2019/12/5 21:19:23Click:1625

        Oyster Point Pharmaceuticals has submitted a NASDAQ listing application to the US Securities and Exchange Commission, and plans to raise $ 85 million in an IPO. This is a biotechnology company dedicated to developing first-in-class therapies for dry ····

        Read More

        The first new mechanism antidepressant in 30 years! Johnson & Johnson Spravato Nasal Spray Submits N

        Author:adminTime:2019/12/5 21:15:38Click:1729

        October 10, 2019 / Bio Valley BIOON /-Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, recently announced that it has submitted a new supplement to the US Food and Drug Administration (FDA) depression drug Spravato (esketamine) CIII nasal spr····

        Read More

        New major depression drug launched! FDA approves new nasal spray formulation with rapid onset of act

        Author:adminTime:2019/12/5 21:14:04Click:1719

        On March 5, local time, the FDA issued a statement saying it agreed to approve the launch of a new nasal spray drug, Spravato (Esketamine), for the treatment of resistant depression. This is the first major depression treatment to enter the US market····

        Read More

        The first new medicine in 20 years! UCB's new epilepsy drug Nayzilam receives FDA approval

        Author:adminTime:2019/11/28 9:52:07Click:1680

        Belgian pharmaceutical company UCB recently announced that the US FDA has approved its latest antiepileptic drug (AED) Nayzilam (midazolam) nasal spray CIV. This is a benzodiazepine drug for nasal administration. It is suitable for the emergency trea····

        Read More

        十八禁黄色网站_91新拍国产在线观看_2018Av天堂在线视频精品观看_国产男女被愉拍在线视频

        <samp id="z604p"><th id="z604p"></th></samp>
        <delect id="z604p"><center id="z604p"></center></delect>

        <optgroup id="z604p"><strike id="z604p"></strike></optgroup>
      2. <video id="z604p"><th id="z604p"></th></video>

          <u id="z604p"></u>
        1. <video id="z604p"><input id="z604p"></input></video>